DaVita Inc. DaVita Inc.

DaVita Inc.

DVA

株式のランク #1791
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
株価
$187.20
最終同期: 2026-10-19
時価総額
$11.94B
変化(1日)
0.21%
変化(1年)
46.19%
国
US
取引 DaVita Inc. (DVA)

カテゴリー

Healthcare
DaVita Inc.(DVA)の発行済株式数
June 2026 時点の発行済株式数 64.78M
DaVita Inc. の最新の財務報告および株価によると、現在の発行済株式数は 64.78M です。December 2024 の終わりには、同社は 84.99M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
DaVita Inc.(DVA)の発行済株式数の履歴(2000 ~ 2026)
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 64.78M -24.76%
2025 86.10M 1.30%
2024 84.99M -6.39%
2023 90.79M -2.37%
2022 92.99M -11.63%
2021 105.23M -12.16%
2020 119.80M -21.79%
2019 153.18M -10.31%
2018 170.79M -9.46%
2017 188.63M -6.45%
2016 201.64M -4.83%
2015 211.87M -0.20%
2014 212.30M 1.13%
2013 209.94M 9.32%
2012 192.04M 1.44%
2011 189.32M -6.74%
2010 203.01M -2.03%
2009 207.21M -1.47%
2008 210.30M -0.70%
2007 211.79M 2.29%
2006 207.04M 2.74%
2005 201.52M 2.06%
2004 197.45M 4.64%
2003 188.69M -12.44%
2002 215.49M -14.25%
2001 251.30M 2.68%
2000 244.74M 0.00%
類似企業や競合他社の発行済株式数